BCI Funding Overview

BCI Funding Overview, September 2026, published by NeuroFounders (neurofounders.co). Funding, valuations and clinical progress across 21 brain-computer interface companies, January 2025 to September 2026. Written by Dominic Borkelmans, Editor-in-chief, NeuroFounders.

Download the full report (PDF)

Key findings

$2.31B in disclosed funding across 20 rounds between January 2025 and September 2026, with 6 further rounds undisclosed.
The 2026 total ($1.27B to 26 September) passed the full 2025 total ($1.04B), driven by four rounds of $230M or more at BrainCo, Merge Labs, Precision and Science.
The five largest raisers took 74% of capital, and 16 of the 21 companies recorded a financing event.
Combined valuation of $15.5B across 8 companies with public or estimated figures; Neuralink accounts for 58% of it.
Chinese companies raised $621M (27%) and North America 73%.
Four companies have products on the market, three of them implanted devices.

Read the report

Overview: capital concentrates as products reach patients — Page 1 of the report. Click to view full size.

Funding events and valuation by company — Page 2 of the report. Click to view full size.

Modality and clinical progress across 21 companies — Page 3 of the report. Click to view full size.

Method and sources by company — Page 4 of the report. Click to view full size.

Open the PDF version

Source: NeuroFounders, neurofounders.co. Information current to 26 September 2026. This report is shared for information only and is not regulatory or investment advice.